Submissions

Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • The manuscript must not have been previously published and must not be under review by another journal. A written explanation should be provided to the Editor via the Comments for Editor section.
  • The submission file is in OpenOffice, Microsoft Word, or RTF document file format, not in PDF.
  • The maximum allowed similarity in manuscripts is 25%. Attach the similarity check result as proof.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.
  • The text is in 1,15 space; uses a 10-point Segoe UI font; employs italics rather than underlining (except with URL addresses); and all illustrations, figures, and tables are positioned in the manuscript near the text that explains them.
  • The total number of tables and figures in the manuscript shall not exceed six (6), and each must be cited in the text
  • The reference list must include at least 20 sources, with a minimum of 80% consisting of primary literature published within the last 10 years.
  • Where available, URLs for the references have been provided.

Author Guidelines

AUTHOR GUIDELINES

Manuscripts for publication in the Jurnal Ilmiah Medicamento are articles on research results in the field of pharmacy (according to the focus and scope of which can be seen in About the Journal) in good and correct Indonesian and English. Manuscripts have not been published in other magazines or journals and must have the appropriate format. Authors are asked to submit the original manuscript by directly submitting the article on the submission link already available on the OJS Web of the Jurnal Ilmiah Medicamento. The author must check the existence and convenience of the document to be opened on another computer. The manuscript is typed in 1.15 spaces (except for the title section, the author's name, and the abstract, which is written in 1 space) on A4-size paper with 10-point font Segoe UI. The text margins are 0.5 inches from the top, bottom, right, and left. Abstracts must be presented in two languages (if the text is in Indonesian), namely Indonesian and English, or in English only (if the text is in English), which are typed in one column, followed by the Introduction, and so on. The original article should be no more than 5000 words (for the main text, from Abstract to Conclusion), and for the review article, it should be no more than 6000 words. Please access this Template in MS Word. Put pictures and tables at the end of the manuscript after the Bibliography section (in the Appendix section), and no more than 6 tables and figures. Manuscripts are presented in the following order:

1. Title (in two languages)

a) Capitalized Each Word

b) Maximum 20 Words

 

2. Abstract (in two languages for Indonesian text)

a) Written 1 paragraph, 200-250 words long, bilingual
b) Objectives, methods, research results, and conclusion
c) Keywords: 3-5 words/phrase

 

3. Introduction

a) There is a clear State of the art
b) There is a clear statement of the gap
c) Research objectives that fill the gaps that have been stated

 

4. Method
a) The research design is clear
For Pharmaceutical science research:
* Tools and Materials are presented in detail and clearly, only including materials that affect research results
* Detailed and precise research procedures, complete with references
* Available ethical clearance (if using experimental animals)
For Clinical and community pharmacy research:
* Population and data collection (sampling technique) presented
* Representative sample size
* Inclusion and exclusion criteria
b) Data analysis techniques are clear

 

5. Results and Discussion

a) Writing numbers and table titles well and correctly
b) Writing the number and title of the picture well and correctly
c) Each table/figure is referred to in the text
d) Comparison with other studies on each data displayed
e) the author's argument related to research results
f) Relevant theory related to existing data

 

6. Conclusions

a) No numbering, 1 paragraph
b) Answer the research objectives concisely and clearly

 

7. Acknowledgments
a) Mention the research sponsor, or if not, mention that the research did not receive funding.
b) Mention if research results have been presented at a scientific conference.

 

8. References

a) The suitability of the bibliography with the text
b) Minimum of 80% is the primary referral
c) New library sources, a maximum of the last ten years
d) Minimum 20 references used
e) Compiled using Reference Manager, such as Mendeley, Zotero, EndNote, etc.

 

PLAGIARISM SCREENING POLICY

The maximum similarity in manuscripts allowed in our journal is 25% (evidenced by the results of a similarity check). If the similarity exceeds the limit, the author must make improvements and resubmit the revised manuscript.

 

PEER REVIEW POLICY

All submitted manuscripts undergo a double-blind peer review process to ensure impartiality and academic integrity. Each manuscript is reviewed by two independent reviewers, with a minimum review period of eight weeks. The evaluation focuses on originality, scientific rigor, and contribution to the field. Final publication decisions are based on reviewers’ recommendations and the editorial board’s assessment.

 

PUBLICATION FEE (article publishing charge)
Each article accepted for publication in JINTO is subject to a publication fee of Rp 1,200,002 (IDR) [starting from publication in 2025].

Submission and Process Fee
There is no charge for submitting and processing articles in Jurnal Ilmiah Medicamento.

Copyright Notice

The copyright holder for the work is the Author.

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

You are free to:

  1. Share — copy and redistribute the material in any medium or format
  2. Adapt — remix, transform, and build upon the material
  3. The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  1. Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  2. NonCommercial — You may not use the material for commercial purposes .
  3. ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  4. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Privacy Statement

At Jurnal Ilmiah Medicamento, we are committed to protecting the privacy of our authors, reviewers, and readers. This privacy statement outlines how we collect, use, and safeguard your personal information when you interact with our journal.

1. Collection of Information
We collect personal information, such as names, email addresses, and institutional affiliations, when users register on our journal's website. This information is used solely for the purposes of managing submissions, editorial processes, and communication regarding journal activities.

2. Use of Information
The collected information is used exclusively for:
a. Managing manuscript submissions and peer review processes.
b. Communicating with authors, reviewers, and editors.
c. Publishing accepted manuscripts.
d. Notifying registered users of journal updates and new publications.

3. Data Protection
We take appropriate security measures to protect personal information from unauthorized access, disclosure, or misuse. Access to user data is restricted to authorized journal staff and editors, who are required to maintain confidentiality.

4. Third-Party Disclosure
We do not share personal information with third parties unless required by law or with the explicit consent of the user. The journal’s website may contain links to external sites, and we are not responsible for their privacy practices.

5. User Rights
Registered users may request access to, correction of, or deletion of their personal data at any time by contacting the journal’s manager at dharmashantini@unmas.ac.id.

6. Updates to this Privacy Statement
We reserve the right to update this privacy statement as necessary. Any changes will be communicated through our journal’s website.

For any privacy-related inquiries, please contact us at medicamento@unmas.ac.id.